HeartBeam, a cardiac technology company, has formed a Strategic Alliance Agreement with Samsung to explore collaboration opportunities in utilizing HeartBeam’s expertise and technology for assessing and monitoring cardiac symptoms at home. HeartBeam acquired the assets of LIVMOR earlier this year.
What You Should Know:
- HeartBeam, a cardiac technology company that has developed the first and only 3D-vector electrocardiogram (VECG) platform intended for patient use at home, announced it has entered into a Strategic Alliance Agreement (SAA) with Samsung, extending the existing SAA between LIVMOR and Samsung.
- Under the terms of the strategic alliance, HeartBeam and Samsung will identify and define opportunities for collaboration, tapping the HeartBeam team’s expertise and patented technology in the assessment and monitoring of cardiac symptoms. HeartBeam acquired the assets of LIVMOR earlier this year.
Source: HitConsultant
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
